Hetero Labs launches generic version of Lapatinib
Hetero Labs has launched a generic version of Lapatinib (250 mg) tablets in India. The product is marketed and distributed under the brand name ‘HERTAB’ […]
Hetero
Hetero Labs acquire Tarbis Farma SLU
Hetero Labs Ltd has acquired Tarbis Farma, S.L.U., a group company of Grupo Ferrer Internacional, SA through its subsidiary Amarox Ltd. The company Tarbis Farma […]
Hetero Healthcare sets up 3 formulation units in AP, Telangana and Assam
Hetero Healthcare, a part of Hetero Drugs, is setting up three units in Andhra Pradesh, Telangana and Assam to expand its formulations business in the […]
Hetero Drugs receives approval for Ledisof
Hetero Drugs has received approval from DCGI to market generic version of Gilead’s Harvoni, a drug used in the treatment of Hepatitis C, in the […]
Hetero Drugs launches bio similar drug of Rituximab
Hetero Drugs has launched a bio similar drug of Roche ‘s Rituximab, under the brand name Maball in Indian market. Rituximab is a monoclonal antibody […]